Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Form 8.3 - Servelec Group plc

24 Nov 2017 10:37

RNS Number : 4678X
Oryx International Growth Fund Ld
24 November 2017
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Oryx International Growth Fund Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Harwood Capital LLP

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Servelec Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

No

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

23 November 2017

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

ORD GBP 0.5

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

900,000

1.29

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

900,000

1.29

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

24 November 2017

Contact name:

Sarah Hendry

BNP Paribas Securities Services S.C.A., Guernsey Branch as Company Secretary

Telephone number:

01481 750822

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETEAEFLADKXFFF
Date   Source Headline
9th Jan 20259:40 amRNSNet Asset Value(s)
9th Dec 202411:08 amRNSNet Asset Value(s)
6th Dec 20244:16 pmRNSHalf-year Report
11th Nov 20241:09 pmRNSNet Asset Value(s)
4th Nov 202412:50 pmRNSDirector/PDMR Shareholding
30th Oct 202410:52 amRNSOffer to acquire GYG Plc
30th Oct 20248:37 amRNSBid for Eckoh plc
8th Oct 20241:16 pmRNSNet Asset Value(s)
17th Sep 202412:10 pmRNSDirector/PDMR Shareholding
13th Sep 20243:19 pmRNSDirector/PDMR Shareholding
13th Sep 20243:16 pmRNSDirector/PDMR Shareholding
13th Sep 20249:42 amRNSDirector/PDMR Shareholding
12th Sep 20243:50 pmRNSDirector/PDMR Shareholding
12th Sep 20243:49 pmRNSDirector/PDMR Shareholding
9th Sep 202412:19 pmRNSNet Asset Value(s)
6th Sep 20242:01 pmRNSDirector/PDMR Shareholding
3rd Sep 20242:46 pmRNSDirector/PDMR Shareholding
2nd Sep 20244:27 pmRNSDirector/PDMR Shareholding
22nd Aug 202410:50 amRNSResult of AGM
9th Aug 20242:31 pmRNSDirector/PDMR Shareholding
8th Aug 202411:24 amRNSNet Asset Value(s)
1st Aug 20247:00 amRNSDirectorate Change
26th Jul 20244:00 pmRNSNotice of AGM
11th Jul 202410:24 amRNSNet Asset Value(s)
10th Jul 20247:00 amRNSInvestor Presentation
4th Jul 20247:00 amRNSAnnual Financial Report
11th Jun 202410:41 amRNSNet Asset Value(s)
10th May 20249:26 amRNSNet Asset Value(s)
10th Apr 20244:34 pmRNSNet Asset Value(s)
15th Mar 202410:01 amRNSHolding(s) in Company
8th Mar 20245:18 pmRNSNet Asset Value(s)
1st Mar 20249:48 amRNSDirector/PDMR Shareholding
26th Feb 202410:54 amRNSDirector/PDMR Shareholding
19th Feb 202411:51 amRNSDirector/PDMR Shareholding
13th Feb 20245:10 pmRNSDirector/PDMR Shareholding
7th Feb 202410:50 amRNSNet Asset Value(s)
18th Jan 20243:19 pmRNSDirector/PDMR Shareholding
15th Jan 20244:35 pmRNSHolding(s) in Company
9th Jan 20244:17 pmRNSNet Asset Value(s)
5th Jan 20249:21 amRNSDirector/PDMR Shareholding
15th Dec 202310:30 amRNSDirector Declaration
11th Dec 202312:52 pmRNSNet Asset Value(s)
21st Nov 202310:21 amRNSHalf-year Report
16th Nov 20238:59 amRNSProposed Sale of The City Pub Group plc
9th Nov 202310:20 amRNSNet Asset Value(s)
19th Oct 20239:00 amRNSInvestment Update
9th Oct 20232:40 pmRNSNet Asset Value(s)
6th Oct 202312:09 pmRNSUpdate on proposed bids for holdings
7th Sep 20235:02 pmRNSNet Asset Value(s)
24th Aug 202310:50 amRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.